POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS)
Clinical trials for POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) explained in plain language.
Never miss a new study
Get alerted when new POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) trials appear
Sign up with your email to follow new studies for POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New POTS drug shows promise in early trial
Symptom relief OngoingThis study tests an experimental drug called REGN7544 in 82 adults with Postural Orthostatic Tachycardia Syndrome (POTS). The goal is to see if a single dose can safely reduce the abnormal heart rate increase that happens when standing up. Researchers will also monitor side effec…
Matched conditions: POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated May 26, 2026 07:53 UTC
-
Skin biopsies could unlock long COVID mysteries
Knowledge-focused OngoingThis study looks at tiny nerve changes in the skin of people with Long COVID, POTS, or diabetic neuropathy. Researchers will compare these changes to better understand how these conditions affect the body's sensory and automatic nervous systems. 300 participants will provide a si…
Matched conditions: POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS)
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 08:04 UTC